Gilead's new HIV med, a bird flu shot for chickens, and Hims does blood tests: Pharma news roundup
Gilead (GILD) said on Tuesday that the U.S. Food and Drug Administration (FDA) has accepted its application for a twice-yearly injectable drug designed to prevent HIV. The U.S. Department of Agriculture (USDA) granted a conditional license for a vaccine designed to protect chickens from the bird flu, in an effort to…